E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/27/2014 in the Prospect News Convertibles Daily.

New Issue: Solazyme prices upsized $130 million 5.5-year convertible notes to yield 5%, up 20%

By Rebecca Melvin

New York, March 27 - Solazyme Inc. priced an upsized $130 million of 5.5-year convertible senior subordinated notes at par to yield 5% with an initial conversion premium of 20%, according to a term sheet.

The registered offering was initially talked at $100 million in size. Pricing came at the rich end of 5% to 5.5% coupon talk and at the 20% talked premium.

Solazyme also priced 5 million shares of common stock at $11.00 per share for $55 million of proceeds.

The notes have a greenshoe of $19.5 million, which was upsized from $15 million.

Goldman Sachs & Co. was the bookrunner for the notes offering, and Goldman and Morgan Stanley & Co. LLC were the bookrunners for the stock offering.

The share offering has a 750,000-share over-allotment option.

The convertibles are non-callable with no investor puts. There is takeover protection and an early conversion payment under which holders with respect to certain conversions occurring before Jan. 1, 2018, will be entitled to receive an early conversion payment of $83.33 per bond in addition to the shares deliverable upon conversion, and that amount may be settled in cash or shares at the company's option.

Proceeds will be used to fund capital expenditures, for working capital and for general corporate purposes.

San Francisco-based Solazyme uses plant-based sugars to produce oils for use in the chemicals and fuels industries, as well as for the nutrition, skin and personal care markets.

Issuer:Solazyme Inc.
Issue:Convertible senior notes
Amount:$130 million, upsized from $100 million
Greenshoe:$19.5 million, upsized from $15 million
Maturity:Oct. 1, 2019
Bookrunner:Goldman Sachs & Co.
Concurrent offering:$55 million of common stock, or 5 million shares at $11.00 each
Coupon:5%
Price:Par
Yield:5%
Conversion premium:20%
Conversion price:$13.20
Conversion ratio:75.7576 shares
Calls:Non-callable
Puts:No
Takeover protection:Yes
Early conversion payment:Yes, $83.33 per bond
Price talk:5%-5.5%, up 20%
Pricing date:March 26
Settlement date:April 1
Distribution:Registered
Stock symbol:Nasdaq: SZYM
Stock price:$11.55 at close March 26
Market capitalization:$760.80 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.